NCT05495932View on ClinicalTrials.gov

Mepolizumab Pharmacokinetics Among Patients With Severe Asthma

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

December 20, 2024

Study Completion Date

December 20, 2024

Conditions
Asthma
Interventions
DIAGNOSTIC_TEST

blood sample

blood sample taken to measure serum mepolizumab concentration at baseline, 1 month and 6 months during study follow-up

Trial Locations (2)

34295

university Hospital of Montpellier, Montpellier

37044

University Hospital of Tours, Tours

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER